FdaApplication

ANDA 201892

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCHARTWELL RX SCIENCES LLC
application_typeANDA
approval_date2018-07-27

Products (2)

ProductActive ingredientStrengthDosage form
RASAGILINE MESYLATERASAGILINE MESYLATEEQ 0.5MG BASETABLET;ORAL
RASAGILINE MESYLATERASAGILINE MESYLATEEQ 1MG BASETABLET;ORAL

2 products